Collegium Pharmaceutical Inc (COLL)
Days of sales outstanding (DSO)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | |
DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
As per the provided data, Collegium Pharmaceutical Inc's Days of Sales Outstanding (DSO) for December 31, 2020, through December 31, 2024, are not available. DSO is a crucial metric that indicates the average number of days it takes for a company to collect payment after making a sale. Unfortunately, the absence of data for these years impedes a detailed analysis of Collegium Pharmaceutical Inc's efficiency in collecting payments from its customers within a specific period. Tracking DSO over time can provide insights into the company's liquidity, credit policies, and potential cash flow issues.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Collegium Pharmaceutical Inc
COLL
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
90.15
Amphastar P
AMPH
67.96
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
7.07
Biomarin Pharmaceutical Inc
BMRN
84.73
Bristol-Myers Squibb Company
BMY
81.21
Catalyst Pharmaceuticals Inc
CPRX
—